Wealthy funder pays reparations for use of HeLa cells
By Alexandra Witze,
Nature
| 10. 29. 2020
Howard Hughes Medical Institute’s six-figure donation is a step towards addressing racial injustice in the sciences.
A major biomedical-research organization has for the first time aimed to make financial reparation for the continuing experimental use of cells from Henrietta Lacks, a Black woman who was the source of the historic ‘HeLa’ cell line, which has been a mainstay of biological research for decades. The Henrietta Lacks Foundation announced the six-figure gift from the Howard Hughes Medical Institute (HHMI) in Chevy Chase, Maryland, on 29 October.
In 1951, doctors took cancerous cells from Lacks without her consent, and later created the HeLa cell line, which today supports a multibillion-dollar biotechnology industry. Lacks died soon after, and for decades, her family saw no financial compensation and were not consulted on other medical decisions stemming from the use of the cells in research.
“We felt it was right to acknowledge Henrietta for the use of HeLa cells and to acknowledge that the cells were gained inappropriately,” says Erin O’Shea, president of the HHMI. “And to acknowledge that we have a long way to go before science and medicine are really equitable.” The HHMI did not disclose the exact amount...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...